(Q54638471)

English

Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease.

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

title

Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease. (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

0 references

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

author name string

R Inzelberg

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

P Nisipeanu

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

M J Rabey

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

language of work or name

English

0 references

publication date

1 September 1995

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

published in

Movement Disorders

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

volume

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

page(s)

604-607

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

Identifiers

DOI

10.1002/MDS.870100512

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

PubMed publication ID

8552112

1 reference

stated in

Europe PubMed Central

PubMed publication ID

8552112

retrieved

1 June 2018

reference URL

http://europepmc.org/abstract/MED/8552112

(Q54638471)

Long-term tolerability and efficacy of cabergoline, a new long-acting dopamine agonist, in Parkinson's disease.

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)